Compugen Ltd. Stock
Your prediction
Compugen Ltd. Stock
Compugen Ltd. took a tumble today and lost €0.000 (-3.440%).
Pros and Cons of Compugen Ltd. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Compugen Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Compugen Ltd. | -3.440% | -15.142% | 18.389% | -30.909% | 18.389% | 65.745% | - |
| Protalix Biotherapeutics Inc. | 13.270% | 28.324% | 48.993% | -4.639% | 45.098% | 50.152% | -37.989% |
| Intellia Therapeutics Inc | 1.530% | -5.795% | 40.256% | 11.240% | 41.622% | -72.941% | -81.167% |
| Chromadex Corp | -2.000% | -6.667% | -7.547% | -9.259% | -10.909% | 163.441% | 25.641% |
Comments
Compugen Ltd. (NASDAQ: CGEN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $4.00 price target on the stock.
Show more
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) had its price target lowered by analysts at Truist Financial Co. from $5.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CGEN provided by MarketBeat
